4
Changes in Ownership
ENDONOVO THERAPEUTICS, INC. Filed Acc 0001645470-19-000031
CEO bought 81,500 shares at an average $0.01 ($1,037)
From the SEC's structured data for this filing
Trades in this filing
Collier Alan Brian · CEO
Table I: Non-derivative
22 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2019-05-13 | Purchase : show line 1 in the form | +2,000 | $0.01 | $25 | 21,754,897 | D |
| 2019-05-13 | Purchase : show line 2 in the form | +50 | $0.01 | $1 | 21,754,947 | D |
| 2019-05-13 | Purchase : show line 3 in the form | +50 | $0.01 | $1 | 21,754,997 | D |
| 2019-05-13 | Purchase : show line 4 in the form | +4,900 | $0.01 | $61 | 21,759,897 | D |
| 2019-05-13 | Purchase : show line 5 in the form | +1,500 | $0.01 | $22 | 21,761,397 | D |
| 2019-05-14 | Purchase : show line 6 in the form | +15,000 | $0.01 | $179 | 21,776,397 | D |
| 2019-05-14 | Purchase : show line 7 in the form | +1,000 | $0.01 | $13 | 21,777,397 | D |
| 2019-05-14 | Purchase : show line 8 in the form | +2,000 | $0.01 | $27 | 21,779,397 | D |
| Open-market purchases · 81,500 sh · avg $0.01 · $1,037 | ||||||
Loading xslF345X03/primary_doc.xml…